Similarly, based on an OS analysis using data from the public database at the BreastMark website, we found that low LOXL4 expression was also associated with poor OS in breast cancer patients, suggesting that LOXL4 expression could be a useful prognostic marker in breast cancer. This evidence concerns the gene LOXL4 and breast cancer.